Product Information
EYE DROPS ADVANCED RELIEF is a generic product labeled by Cardinal Health, priced at $0.1520 per ML under NDC 70000045601. Its NADAC has been published 372 times since Aug 21, 2019.
EYE DROPS ADVANCED RELIEF
DEXTRAN 70, POLYETHYLENE GLYCOL 400, POVIDONE, TETRAHYDROZOLINE HClStrength
100; 1000; 1000; 50 mg/100mL; mg/100mL; mg/100mL; mg/100mL
Manufacturer
Cardinal HealthNDC
70000045601
Classification
Generic
Dosage Form
SOLUTION/ DROPS
Route
OPHTHALMIC
Effective Date
6/17/2026
Approval Type
OTC MONOGRAPH DRUG
FDA Application
M018On Market Since
2/19/2019
Pharmacological Classes
Price Statistics
The NADAC for EYE DROPS ADVANCED RELIEF has been published 372 times since Aug 21, 2019, and over the history we have for it it has risen 57.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1520 per ML |
|---|---|
| All-time high | $0.1677 (Aug 16, 2023) |
| All-time low | $0.0929 (Feb 19, 2020) |
| 52-week high | $0.1520 |
| 52-week low | $0.1420 |
| Median price | $0.1407 |
| Average price | $0.1364 |
| Largest weekly change | +39.7% (Mar 18, 2020) |
| Weeks tracked | 372 |
| Tracking since | Aug 21, 2019 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the DEXTRAN 70, POLYETHYLENE GLYCOL 400, POVIDONE, TETRAHYDROZOLINE HCl market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Cardinal Health manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
DEXTRAN 70, POLYETHYLENE GLYCOL 400, POVIDONE, TETRAHYDROZOLINE HCl market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Plasma Volume Expander class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of EYE DROPS ADVANCED RELIEF?
The current National Average Drug Acquisition Cost (NADAC) for EYE DROPS ADVANCED RELIEF, manufactured by Cardinal Health, is $0.1520 per ML (NDC 70000045601), effective Sep 30, 2026.
How has the price of EYE DROPS ADVANCED RELIEF changed over time?
Over the history we have for it, the NADAC for EYE DROPS ADVANCED RELIEF has risen 57.0%. It has been tracked across 372 weekly CMS publications since Aug 21, 2019.
What are the highest and lowest recorded NADAC prices for EYE DROPS ADVANCED RELIEF?
Since Aug 21, 2019, the NADAC for EYE DROPS ADVANCED RELIEF has ranged from a low of $0.0929 (Feb 19, 2020) to a high of $0.1677 (Aug 16, 2023), with a median of $0.1407 per ML.
Are there cheaper alternatives to EYE DROPS ADVANCED RELIEF?
No other NADAC-published product currently shares the active ingredient and strength of EYE DROPS ADVANCED RELIEF in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures EYE DROPS ADVANCED RELIEF?
EYE DROPS ADVANCED RELIEF (NDC 70000045601) is labeled by Cardinal Health, and CMS classifies it as a generic product.